Recent Changes to National Cholesterol Education Program Guidelines Highlight Need for Novel Therapeutic Approaches

Strategic Insights -

Expert analysts attending the 7th Annual Scientific Forum of the National Lipid Association (NLA) have expressed concerns about the increasing risk of heart disease in patients with lipid disorders, particularly those with low-density lipoprotein (LDL) cholesterol levels above 70 mg/dL. Recent clinical trials have shown that substantial reductions in LDL-cholesterol levels are necessary to mitigate this risk. Achieving these new goals will require healthcare professionals to develop tailored therapeutic strategies, combining statins with other lipid-lowering agents such as bile acid sequestrants, cholesterol absorption inhibitors, and nicotinic acid.

Key Takeaways:

  • The National Cholesterol Education Program (NCEP) guidelines require a substantial reduction in LDL-cholesterol levels to less than 70 mg/dL in very high-risk patients to reduce the risk of heart disease.
  • Recent clinical trials have shown that single-drug use, primarily with statins, may not be adequate to achieve these new LDL cholesterol goals.
  • Bile acid sequestrants, cholesterol absorption inhibitors, and nicotinic acid may be used in combination to determine the most safe and effective therapy for patients with high cholesterol.
  • The role of HDL (good) cholesterol and triglycerides in cardiovascular disease will be discussed in upcoming presentations.
  • Emerging therapies in the management of high cholesterol will also be presented at the NLA Scientific Forum.

Statistics:

  • More than 1,000 physicians, nurses, pharmacists, physician assistants, dieticians, and their practices are represented by the National Lipid Association (NLA).
  • Heart disease is a significant risk for patients with lipid disorders, particularly those with LDL-cholesterol levels above 70 mg/dL.
  • 70 mg/dL is the new goal for LDL-cholesterol levels in very high risk patients, as recommended by the NCEP.

Sources:

  • NewsRx.com & NewsRx.net, 2004 SEP 12
  • Heart Disease Weekly editors, 2004
  • Neil J. Stone, MD, Feinberg School of Medicine at Northwestern University
  • Peter H. Jones, MD, Baylor College of Medicine
  • National Lipid Association (NLA)